Australia pledges Aus$292m for medical research:
This article was originally published in Clinica
Australia has pledged Aus$292m (US$221m) in a first round of funding for medical research to commence in 2006. In all, 600 projects will be conducted across 52 institutions, including universities, hospitals and medical research institutes. Some of the projects relevant to medical technology include: prostate cancer outcomes study; study on cervical health; developing a new patient-centred adverse event reporting tool; and a follow-up of the International Breast Cancer Intervention Study (a prevention trial for women at high risk). A full list of the projects and funding amounts can be found at: www.nhmrc.gov.au/funding/fundedoutcomes/index.htm
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.